Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nastya Kassir

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|July 6, 2023
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib dataNastya Kassir, Phyllis Chan, Steve Dang, et al.
Clinical Pharmacology and Therapeutics|October 13, 2023
Machine Learning-Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis: Insights from Etrolizumab Phase III Clinical TrialsRashed Harun, James Lu, Nastya Kassir, et al.
Pharmaceutics|May 27, 2023
Machine Learning for Exposure-Response Analysis: Methodological Considerations and Confirmation of Their Importance via Computational ExperimentationsRashed Harun, Eric Yang, Nastya Kassir, et al.
Journal of Clinical Pharmacology|March 14, 2020
Population Pharmacokinetics and Exposure Response Analysis of Pomalidomide in Subjects With Relapsed or Refractory Multiple Myeloma From the Novel Combination Treatment of Pomalidomide, Bortezomib, and Low-Dose DexamethasoneYan Li, Nastya Kassir, Xiaomin Wang, et al.
Clinical and Translational Science|May 15, 2020
Pharmacokinetics, Pharmacodynamics, and Exposure-Response of Lanadelumab for Hereditary AngioedemaYi Wang, Jean-Francois Marier, Nastya Kassir, et al.
Journal of Clinical Pharmacology|March 3, 2020
Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1), in Patients With Ulcerative Colitis or Crohn's DiseaseYi Wang, Jean-Francois Marier, Jean Lavigne, et al.
Clinical Pharmacology in Drug Development|May 28, 2020
Population Pharmacokinetics and Exposure-Response Analysis of nab-Paclitaxel in Pediatric Patients With Recurrent or Refractory Solid TumorsYan Li, Nastya Kassir, Nianhang Chen, et al.
The AAPS Journal|November 6, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric PatientsOlagoke Sule, Felix Stader, Nastya Kassir, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|September 6, 2017
Dose-Exposure Simulation for Piperacillin-Tazobactam Dosing Strategies in Infants and Young ChildrenCéline Thibault, Nastya Kassir, Yves Théorêt, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and ChildrenCéline Thibault, Jean Lavigne, Catherine Litalien, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|July 6, 2023
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib dataNastya Kassir, Phyllis Chan, Steve Dang, et al.
Clinical Pharmacology and Therapeutics|October 13, 2023
Machine Learning-Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis: Insights from Etrolizumab Phase III Clinical TrialsRashed Harun, James Lu, Nastya Kassir, et al.
Pharmaceutics|May 27, 2023
Machine Learning for Exposure-Response Analysis: Methodological Considerations and Confirmation of Their Importance via Computational ExperimentationsRashed Harun, Eric Yang, Nastya Kassir, et al.
Journal of Clinical Pharmacology|March 14, 2020
Population Pharmacokinetics and Exposure Response Analysis of Pomalidomide in Subjects With Relapsed or Refractory Multiple Myeloma From the Novel Combination Treatment of Pomalidomide, Bortezomib, and Low-Dose DexamethasoneYan Li, Nastya Kassir, Xiaomin Wang, et al.
Clinical and Translational Science|May 15, 2020
Pharmacokinetics, Pharmacodynamics, and Exposure-Response of Lanadelumab for Hereditary AngioedemaYi Wang, Jean-Francois Marier, Nastya Kassir, et al.
Journal of Clinical Pharmacology|March 3, 2020
Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1), in Patients With Ulcerative Colitis or Crohn's DiseaseYi Wang, Jean-Francois Marier, Jean Lavigne, et al.
Clinical Pharmacology in Drug Development|May 28, 2020
Population Pharmacokinetics and Exposure-Response Analysis of nab-Paclitaxel in Pediatric Patients With Recurrent or Refractory Solid TumorsYan Li, Nastya Kassir, Nianhang Chen, et al.
The AAPS Journal|November 6, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric PatientsOlagoke Sule, Felix Stader, Nastya Kassir, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|September 6, 2017
Dose-Exposure Simulation for Piperacillin-Tazobactam Dosing Strategies in Infants and Young ChildrenCéline Thibault, Nastya Kassir, Yves Théorêt, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and ChildrenCéline Thibault, Jean Lavigne, Catherine Litalien, et al.
Pageof 5